Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer of the Bladder and Kidney

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The purpose of this study is to determine if analysis of DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney. This analysis may be helpful to determine if how a particular cancer will act regarding remission and recurrence

Who May Be Eligible (Plain English)

Who May Qualify: - Patients scheduled to have a nephroureterectomy, cystectomy, cytoscopy (newly diagnosed bladder cancer and those with recurrent disease in follow up) - Control Group: No known evidence of bladder cancer-one urine sample - \> than 18 years of age Who Should NOT Join This Trial: - \< than 18 years of age Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patients scheduled to have a nephroureterectomy, cystectomy, cytoscopy (newly diagnosed bladder cancer and those with recurrent disease in follow up) * Control Group: No known evidence of bladder cancer-one urine sample * \> than 18 years of age Exclusion Criteria: * \< than 18 years of age

Locations (1)

Lahey Clinic, Inc.
Burlington, Massachusetts, United States